Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas (clinicaltrials.gov) - Sep 30, 2026 - P1 | N=20 | Completed | Sponsor: Alaunos Therapeutics | Unknown status ➔ Completed
Trial completion • Hematological Malignancies • Lymphoma • Oncology • Solid Tumor
|